Pharma/Biotech GTN Summit
Pharmaceutical Gross-to-Net Insights
Stay ahead of evolving gross-to-net management through our curated collection of expert interviews, session highlights, and practical insights highlighting topics on rebate management, forecasting accuracy, and optimizing net revenue performance.
Lifestar Pharma's Journey and the Evolving Generic Pharmaceutical Landscape
"GTN is getting more complicated day by day for generics as it's not easy to forecast certain concessions like price protection and shelf stock adjustments."
We spoke with Prakash Chainani, Vice President of Finance, HR & IT at Lifestar Pharma to learn about the evolving landscape of generic pharmaceuticals.
Hot Topics to Watch at the 2025 Pharma/Biotech GTN Summit
- Medicare Negotiation Program Implementation: Sessions covering the real-world impact of the first rounds of Medicare drug price negotiations that began taking effect in January 2026
- Inflation Reduction Act Compliance: Strategies for navigating the "IRA Watchdog" coalition's findings and pharmaceutical industry responses
- Policy Intersections: How recent executive orders and legislative developments are reshaping pharmaceutical pricing strategies
- AI-Powered GTN Management: How artificial intelligence (valued at $1.94 billion in the pharmaceutical sector in 2025) is revolutionizing gross-to-net calculations
- System Integration Strategies: Debates on multiple systems versus integrated platforms for GTN management
- GTN Dashboards & Analytics: Advanced visualization tools for variance analysis, trend monitoring, and predictive modeling
- Data Governance Frameworks: Building robust infrastructure and validation processes for GTN data integrity
- Risk Management & Controls: Implementing effective protocols to ensure financial compliance
- Cross-Collaboration Improvements: Breaking down silos between finance, market access, and commercial teams
Session Spotlights
Explore the future of GTN and financial leadership through five strategic pillars. Participants can expect discussions on how digital transformation and advanced analytics are revolutionizing financial decision-making, alongside operational excellence frameworks to standardize processes across global operations.
A comprehensive overview of the evolving healthcare landscape, focusing on government programs and pharmacy benefit management. Attendees will gain insights into implementation timelines for new healthcare policies, along with specific updates on Medicare programs and emerging Medicaid developments.
Join this session to address critical challenges in maintaining data accuracy, governance, and quality to achieve optimal business outcomes. Participants will explore essential frameworks and infrastructure needed to support robust data management systems, along with validation processes that ensure data integrity throughout its lifecycle
Key topics being explored at GTN Summit
What gross-to-net methodologies will be covered at the summit?
The summit provides comprehensive coverage of various GTN methodologies including accrual management, reserve analysis, forecasting techniques, and reconciliation processes. Sessions focus on practical applications tailored for both established pharma companies and emerging biotechs.
How will the summit address technological innovation in GTN management?
The summit explores cutting-edge financial automation tools, blockchain integration with planning platforms, and network collaboration solutions. Previous sessions have featured demonstrations of how these technologies can improve GTN accuracy and streamline processes.
What forecasting models will be discussed for different company sizes?
The summit offers specialized tracks designed for different company sizes - from Big Pharma to emerging biotech. Sessions cover forecasting models appropriate for pre-commercial organizations as well as those managing multiple products and large revenue streams.
How will the summit address current regulatory challenges affecting GTN?
Sessions will cover critical regulatory topics including CoPay accumulator programs and recent rulings, Medicare Part D impacts on GTN, and evolving Medicaid and 340B forecasting requirements that directly affect pharmaceutical pricing and revenue.
What market access and pricing content will be featured?
The summit includes dedicated sessions on product pricing pressures within the payer marketplace, patient access benefits assessment, and strategies for managing the impact of market dynamics on gross-to-net calculations.
How will government pricing policies be addressed in the program?
The program features specialized sessions on government pricing considerations, including Medicaid and 340B forecasting, led by industry experts.